Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,969 | -8,589 | -5,019 | -3,316 | -1,571 |
| Depreciation Amortization | 189 | 748 | 559 | 370 | 183 |
| Accounts payable and accrued liabilities | 218 | 118 | 34 | 140 | 199 |
| Other Working Capital | 536 | 1,799 | 124 | 408 | 302 |
| Other Operating Activity | -147 | 254 | 130 | -36 | -146 |
| Operating Cash Flow | $-1,172 | $-5,670 | $-4,172 | $-2,433 | $-1,033 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -152 | -149 | -90 | -45 |
| Investing Cash Flow | $-8 | $-152 | $-149 | $-90 | $-45 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -95 | -95 | -95 | -71 |
| Financing Cash Flow | $N/A | $-95 | $-95 | $-95 | $-71 |
| Beginning Cash Position | 8,150 | 14,066 | 14,066 | 14,066 | 14,066 |
| End Cash Position | 6,970 | 8,150 | 9,651 | 11,448 | 12,918 |
| Net Cash Flow | $-1,180 | $-5,917 | $-4,415 | $-2,618 | $-1,148 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,172 | -5,670 | -4,172 | -2,433 | -1,033 |
| Capital Expenditure | -8 | -152 | -149 | -90 | -45 |
| Free Cash Flow | -1,180 | -5,822 | -4,321 | -2,523 | -1,077 |